Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for February 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Wyeth to open clinical trial 'Super Centres'
Wyeth plans to streamline drug development operations..(more)

 Pegasys recommended as front line hepatitis B treatment
Pegasys set to be used more widely in England and Wales..(more)

 Pfizer's new blood infection drug Eraxis approved
Pfizer hoping new drug can follow in the footsteps of Diflucan..(more)

 Sanofi's wonder drug in limbo after regulator's rejection
FDA's reservations coulld scupper treatment..(more)

 Gene silencing technology to be used in war against bird flu
Novartis to team up with US-based Alnylam..(more)

 Tysabri trials restart after safety scare
Trials restart one year after drug's suspension..(more)

 Merck files novel diabetes drug Januvia
Januvia could provide step forward for type II diabetes..(more)

 Woman loses Herceptin court case
Swindon PCT taken to court over Herceptin..(more)

 Avastin trial recruitment suspended after patient deaths
Speed of recruitment also an issue for safety Board..(more)

 WHO calls for action on counterfeits
WHO aims to put together world task force..(more)

 Wyeth joins search for promising TLR drugs
Dublin-based Opsona to develop medicines to target TLRs..(more)

 Safety scare spells the end for Exanta
AstraZeneca pledges to pursue other thrombosis treatments..(more)

 Talman and Crozier launch new PR agency
New agency to redefine client/agency relationship..(more)

 GSK looks ahead to surge of products in 2006
New ffilings. approvals and launches expected..(more)

 More Tamiflu released for UK areas hit by seasonal flu
Tiight control maintained on supplies..(more)

 Abbott suspended from ABPI over sleaze
Misconduct requires strict punishment..(more)

 Doctors warn on new medical assistant proposals
Fears for doctor training..(more)

 GSK's research chief leaves for Gates Foundation
Slaoui named as successor..(more)

 Pfizer considers sale of OTC division
Sale could fetch $10 biillion..(more)

 'Break even culture' must end, Hewitt tells NHS
Health secretary pushed ahead with radical reform..(more)

 Europe approves first ever biotech generic
Sandoz's Omnitrope world's first 'biosimilar' ..(more)

 Big drop in animal rights attacks
ABPI figures show animal rights attacks fell last year..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.